MedRx Co., Ltd

TSE:4586 Stock Report

Market Cap: JP¥4.1b

MedRx Valuation

Is 4586 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 4586 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 4586's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 4586's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4586?

Key metric: As 4586 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 4586. This is calculated by dividing 4586's market cap by their current revenue.
What is 4586's PS Ratio?
PS Ratio16.2x
SalesJP¥255.00m
Market CapJP¥4.13b

Price to Sales Ratio vs Peers

How does 4586's PS Ratio compare to its peers?

The above table shows the PS ratio for 4586 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average22.4x
4889 Renascience
26.9xn/aJP¥3.8b
4539 Nippon Chemiphar
0.2xn/aJP¥5.5b
4888 Stella Pharma
59xn/aJP¥16.8b
4579 RaQualia Pharma
3.6x9.6%JP¥10.0b
4586 MedRx
16.2xn/aJP¥4.1b

Price-To-Sales vs Peers: 4586 is good value based on its Price-To-Sales Ratio (16.2x) compared to the peer average (22.4x).

Price to Sales Ratio vs Industry

How does 4586's PS Ratio compare vs other companies in the JP Pharmaceuticals Industry?

3 CompaniesPrice / SalesEstimated GrowthMarket Cap
4541 Nichi-Iko Pharmaceutical
0.1xn/aUS$185.57m
8095 Astena Holdings
0.4xn/aUS$127.91m
4539 Nippon Chemiphar
0.2xn/aUS$35.21m
No more companies available in this PS range
4586 16.2xIndustry Avg. 1.9xNo. of Companies6PS01.63.24.86.48+
3 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 4586 is expensive based on its Price-To-Sales Ratio (16.2x) compared to the JP Pharmaceuticals industry average (1.9x).

Price to Sales Ratio vs Fair Ratio

What is 4586's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4586 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio16.2x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 4586's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Tsumura

JP¥368.9b

Manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally.

4540

JP¥4,858.00

7D

1.2%

1Y

76.3%

Shionogi

JP¥1.8t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

4507

JP¥2,094.50

7D

-2.1%

1Y

-10.9%

Daito PharmaceuticalLtd

JP¥32.8b

Manufactures and sells pharmaceutical products worldwide.

4577

JP¥2,147.00

7D

1.8%

1Y

8.8%